Latest Articles
Research progress and future directions in circadian rhythms for uterine‑related diseases (Review).
Circadian rhythms are ~24 h endogenous rhythms driven by both central and peripheral clocks, with their core mechanism being a transcription‑translation feedback loop mediated by master clock genes. The present …
Published: April 30, 2026, midnight
The Endometrial Cancer Treatment Landscape - OncLive
The Endometrial Cancer Treatment Landscape OncLive
Published: April 29, 2026, 12:15 p.m.
Hebrew University Researchers Identify RNA Dicing as Key Driver of JAK1 Oncogenic Activity in Endometrial Cancer - MedicalResearch.com
Hebrew University Researchers Identify RNA Dicing as Key Driver of JAK1 Oncogenic Activity in Endometrial Cancer MedicalResearch.com
Published: April 29, 2026, 10:59 a.m.
ADCs Reshaping Endometrial Cancer Care - OncLive
ADCs Reshaping Endometrial Cancer Care OncLive
Published: April 28, 2026, 12:32 p.m.
HER2 Testing and Treatment Selection in Endometrial Cancer - OncLive
HER2 Testing and Treatment Selection in Endometrial Cancer OncLive
Published: April 28, 2026, 12:32 p.m.
Endometrial Cancer Pipeline Grows as 50+ Pharma Companies - openPR.com
Endometrial Cancer Pipeline Grows as 50+ Pharma Companies openPR.com
Published: April 27, 2026, 10:04 p.m.
Clinical Practice Insights: Pharmacists Managing Advanced Endometrial Cancer - Pharmacy Times
Clinical Practice Insights: Pharmacists Managing Advanced Endometrial Cancer Pharmacy Times
Published: April 27, 2026, 1:35 p.m.
Near-perfect disease control for bispecific in advanced endometrial cancer - MSN
Near-perfect disease control for bispecific in advanced endometrial cancer MSN
Published: April 27, 2026, 1:41 a.m.
Near-perfect disease control for bispecific in advanced endometrial cancer - msn.com
Near-perfect disease control for bispecific in advanced endometrial cancer msn.com
Published: April 27, 2026, 1:41 a.m.
Why BioNTech (BNTX) Is Up 9.2% After Strong Phase 2 HER2 ADC Data In Endometrial Cancer - Yahoo Finance
Why BioNTech (BNTX) Is Up 9.2% After Strong Phase 2 HER2 ADC Data In Endometrial Cancer Yahoo Finance
Published: April 23, 2026, 8:06 p.m.
Link copied to clipboard!